Inogen (INGN) Interest & Investment Income (2013 - 2026)
Inogen's (INGN) quarterly Interest & Investment Income came in at $880000.0 in Q1 2026, down 14.48% year-on-year from $1.0 million in Q1 2025, and down 24.33% on a QoQ basis from $1.2 million in Q4 2025.
Inogen (INGN) Interest & Investment Income (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Interest & Investment Income data on file, last reported at $880000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 14.48% year-over-year to $880000.0 in Q1 2026; TTM through Mar 2026 was $4.2 million, a 12.04% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, down 15.51% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $880000.0, down from $1.2 million in the prior quarter.
- Over the last five years, Interest & Investment Income for INGN reached as high as $1.8 million in Q3 2023 and fell as low as $29000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.2 million across 5 years, with a median of $1.2 million in 2025.
- On a YoY basis, Interest & Investment Income climbed as much as 7695.45% in 2022 and fell as far as 49.12% in 2022.
- Year by year, Interest & Investment Income stood at $1.7 million in 2022, then fell by 6.59% to $1.6 million in 2023, then dropped by 11.8% to $1.4 million in 2024, then dropped by 17.69% to $1.2 million in 2025, then declined by 24.33% to $880000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $880000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Inogen | 173.63 Mn | 63.46 Mn | 37.86 Mn | 880,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 880,000.00 |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 1.80 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 1.72 Mn |
| Sep 30, 2022 | 868,000.00 |
| Jun 30, 2022 | 225,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 21,000.00 |
| Jun 30, 2021 | 29,000.00 |